Podcast: Download (Duration: 11:48 — 10.8MB) | Embed
Nadav Kidron, Oramed’s CEO called into SmallCapVoice.com to explain that Oramed Pharmaceuticals Inc. (OTCBB: ORMP) is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed’s technology is based on over 25 years of research by top research scientists at Jerusalem’sHadassah Medical Center. The Company’s corporate and R&D headquarters are based in Jerusalem.
